 | • レポートコード：QYR9ST15034 • 出版社/出版日：QYResearch / 2019年9月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、非経口薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、LVP薬、SVP薬に、用途別には、病院、医療センター、その他にセグメント区分し、非経口薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・非経口薬の世界市場概要 ・非経口薬の製造コスト構成分析 ・非経口薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・非経口薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・非経口薬のセグメント分析（種類別） （LVP薬、SVP薬） ・非経口薬のセグメント分析（用途別） （病院、医療センター、その他） ・非経口薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Ostuka Pharmaceutical、Teva Pharmaceutical Industries、Kelun Pharma、Cook Pharmica、Patheon、BAG Healthcare、Beximco Pharma、Baxter Healthcare Corporation、B. Braun、Fresenius、Albert David、BML Parenteral Drugs、Pfizer (Hospira)、Pisa、Ozon Pharmaceuticals Ltd、Aspen Holdings、PSI Ltd、Wintac Limited、AXA Parenterals Ltd、Acebright、Southwest Pharmaceutical、Abbott） ・非経口薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a “catch-all” for all non-LVP parenterals products except biologicals.Parenteral drugs, whether a small-molecule or biologic-based drug substance, has increased their share of the overall drug market although solid-dosage products still prevail.
The global Parenteral Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Parenteral Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parenteral Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Parenteral Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Parenteral Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
Segment by Regions
North America
Europe
China
Japan
Segment by Type
LVP Drug
SVP Drug
＞100ml
＜100ml
Segment by Application
Hospitals
Medical Centers
Others
Table of Contents
Executive Summary
1 Industry Overview of Parenteral Drugs
1.1 Definition of Parenteral Drugs
1.2 Parenteral Drugs Segment by Type
1.2.1 Global Parenteral Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs Segment by Applications
1.3.1 Global Parenteral Drugs Consumption Comparison by Applications (2014-2025)
1.5.2 Hospitals
1.5.3 Medical Centers
1.5.4 Others
1.4 Global Parenteral Drugs Overall Market
1.4.1 Global Parenteral Drugs Revenue (2014-2025)
1.4.2 Global Parenteral Drugs Production (2014-2025)
1.4.3 North America Parenteral Drugs Status and Prospect (2014-2025)
1.4.4 Europe Parenteral Drugs Status and Prospect (2014-2025)
1.4.5 China Parenteral Drugs Status and Prospect (2014-2025)
1.4.6 Japan Parenteral Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parenteral Drugs
2.3 Manufacturing Process Analysis of Parenteral Drugs
2.4 Industry Chain Structure of Parenteral Drugs
3 Development and Manufacturing Plants Analysis of Parenteral Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Parenteral Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Parenteral Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Parenteral Drugs Production and Capacity Analysis
4.2 Parenteral Drugs Revenue Analysis
4.3 Parenteral Drugs Price Analysis
4.4 Market Concentration Degree
5 Parenteral Drugs Regional Market Analysis
5.1 Parenteral Drugs Production by Regions
5.1.1 Global Parenteral Drugs Production by Regions
5.1.2 Global Parenteral Drugs Revenue by Regions
5.2 Parenteral Drugs Consumption by Regions
5.3 North America Parenteral Drugs Market Analysis
5.3.1 North America Parenteral Drugs Production
5.3.2 North America Parenteral Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Parenteral Drugs Import and Export
5.4 Europe Parenteral Drugs Market Analysis
5.4.1 Europe Parenteral Drugs Production
5.4.2 Europe Parenteral Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Parenteral Drugs Import and Export
5.5 China Parenteral Drugs Market Analysis
5.5.1 China Parenteral Drugs Production
5.5.2 China Parenteral Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Parenteral Drugs Import and Export
5.6 Japan Parenteral Drugs Market Analysis
5.6.1 Japan Parenteral Drugs Production
5.6.2 Japan Parenteral Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Parenteral Drugs Import and Export
6 Parenteral Drugs Segment Market Analysis (by Type)
6.1 Global Parenteral Drugs Production by Type
6.2 Global Parenteral Drugs Revenue by Type
6.3 Parenteral Drugs Price by Type
7 Parenteral Drugs Segment Market Analysis (by Application)
7.1 Global Parenteral Drugs Consumption by Application
7.2 Global Parenteral Drugs Consumption Market Share by Application (2014-2019)
8 Parenteral Drugs Major Manufacturers Analysis
8.1 Ostuka Pharmaceutical
8.1.1 Ostuka Pharmaceutical Parenteral Drugs Production Sites and Area Served
8.1.2 Ostuka Pharmaceutical Product Introduction, Application and Specification
8.1.3 Ostuka Pharmaceutical Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Teva Pharmaceutical Industries
8.2.1 Teva Pharmaceutical Industries Parenteral Drugs Production Sites and Area Served
8.2.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.2.3 Teva Pharmaceutical Industries Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Kelun Pharma
8.3.1 Kelun Pharma Parenteral Drugs Production Sites and Area Served
8.3.2 Kelun Pharma Product Introduction, Application and Specification
8.3.3 Kelun Pharma Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cook Pharmica
8.4.1 Cook Pharmica Parenteral Drugs Production Sites and Area Served
8.4.2 Cook Pharmica Product Introduction, Application and Specification
8.4.3 Cook Pharmica Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Patheon
8.5.1 Patheon Parenteral Drugs Production Sites and Area Served
8.5.2 Patheon Product Introduction, Application and Specification
8.5.3 Patheon Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 BAG Healthcare
8.6.1 BAG Healthcare Parenteral Drugs Production Sites and Area Served
8.6.2 BAG Healthcare Product Introduction, Application and Specification
8.6.3 BAG Healthcare Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Beximco Pharma
8.7.1 Beximco Pharma Parenteral Drugs Production Sites and Area Served
8.7.2 Beximco Pharma Product Introduction, Application and Specification
8.7.3 Beximco Pharma Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Baxter Healthcare Corporation
8.8.1 Baxter Healthcare Corporation Parenteral Drugs Production Sites and Area Served
8.8.2 Baxter Healthcare Corporation Product Introduction, Application and Specification
8.8.3 Baxter Healthcare Corporation Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 B. Braun
8.9.1 B. Braun Parenteral Drugs Production Sites and Area Served
8.9.2 B. Braun Product Introduction, Application and Specification
8.9.3 B. Braun Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Fresenius
8.10.1 Fresenius Parenteral Drugs Production Sites and Area Served
8.10.2 Fresenius Product Introduction, Application and Specification
8.10.3 Fresenius Parenteral Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Albert David
8.12 BML Parenteral Drugs
8.13 Pfizer (Hospira)
8.14 Pisa
8.15 Ozon Pharmaceuticals Ltd
8.16 Aspen Holdings
8.17 PSI Ltd
8.18 Wintac Limited
8.19 AXA Parenterals Ltd
8.20 Acebright
8.21 Southwest Pharmaceutical
8.22 Abbott
9 Development Trend of Analysis of Parenteral Drugs Market
9.1 Global Parenteral Drugs Market Trend Analysis
9.1.1 Global Parenteral Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Parenteral Drugs Regional Market Trend
9.2.1 North America Parenteral Drugs Forecast 2019-2025
9.2.2 Europe Parenteral Drugs Forecast 2019-2025
9.2.3 China Parenteral Drugs Forecast 2019-2025
9.2.4 Japan Parenteral Drugs Forecast 2019-2025
9.3 Parenteral Drugs Market Trend (Product Type)
9.4 Parenteral Drugs Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Parenteral Drugs Distributors List
10.3 Parenteral Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Parenteral Drugs
Table Global Parenteral Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Parenteral Drugs Production Market Share by Types in 2018
Figure LVP Drug Product Picture
Figure SVP Drug Product Picture
Table Global Parenteral Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Parenteral Drugs Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Medical Centers
Figure Others
Figure Global Parenteral Drugs Revenue (Million USD) (2014-2025)
Figure Global Parenteral Drugs Production (K Units) (2014-2025)
Figure North America Parenteral Drugs Market Size (Million USD) (2014-2025)
Figure Europe Parenteral Drugs Market Size (Million USD) (2014-2025)
Figure China Parenteral Drugs Market Size (Million USD) (2014-2025)
Figure Japan Parenteral Drugs Market Size (Million USD) (2014-2025)
Table Manufacturing Cost Structure Analysis of Parenteral Drugs in 2018
Figure Manufacturing Process Analysis of Parenteral Drugs
Figure Industry Chain Structure of Parenteral Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Parenteral Drugs Manufacturing Plants Distribution
Table Parenteral Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Parenteral Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Parenteral Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Parenteral Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Parenteral Drugs Production Share by Manufacturers in 2018
Table Parenteral Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Parenteral Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Parenteral Drugs Revenue Share by Manufacturers in 2018
Table Parenteral Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Parenteral Drugs Production by Regions 2014-2019 (K Units)
Table Global Parenteral Drugs Production Market Share by Regions 2014-2019
Figure Global Parenteral Drugs Production Market Share by Regions in 2018
Table Global Parenteral Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Parenteral Drugs Revenue Market Share by Regions 2014-2019
Figure Global Parenteral Drugs Revenue Market Share by Regions in 2018
Table Global Parenteral Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Parenteral Drugs Consumption Market Share by Regions 2014-2019
Figure North America Parenteral Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Parenteral Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Parenteral Drugs Production, Consumption Import and Export (K Units)
Figure Europe Parenteral Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Parenteral Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Parenteral Drugs Production, Consumption Import and Export (K Units)
Figure China Parenteral Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Parenteral Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Parenteral Drugs Production, Consumption Import and Export (K Units)
Figure Japan Parenteral Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Parenteral Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Parenteral Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Parenteral Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Parenteral Drugs Market Share by Application (2014-2019)
Table Ostuka Pharmaceutical Parenteral Drugs Production Sites and Area Served
Table Ostuka Pharmaceutical Parenteral Drugs Product Introduction, Application and Specification
Table Ostuka Pharmaceutical Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Ostuka Pharmaceutical Parenteral Drugs Production Growth Rate (2014-2019)
Table Ostuka Pharmaceutical Parenteral Drugs Production Market Share (2014-2019)
Figure Ostuka Pharmaceutical Parenteral Drugs Revenue Market Share (2014-2019)
Table Ostuka Pharmaceutical Parenteral Drugs Main Business and Markets Served
Table Teva Pharmaceutical Industries Parenteral Drugs Production Sites and Area Served
Table Teva Pharmaceutical Industries Parenteral Drugs Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Parenteral Drugs Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Parenteral Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Parenteral Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Parenteral Drugs Main Business and Markets Served
Table Kelun Pharma Parenteral Drugs Production Sites and Area Served
Table Kelun Pharma Parenteral Drugs Product Introduction, Application and Specification
Table Kelun Pharma Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Kelun Pharma Parenteral Drugs Production Growth Rate (2014-2019)
Table Kelun Pharma Parenteral Drugs Production Market Share (2014-2019)
Figure Kelun Pharma Parenteral Drugs Revenue Market Share (2014-2019)
Table Kelun Pharma Parenteral Drugs Main Business and Markets Served
Table Cook Pharmica Parenteral Drugs Production Sites and Area Served
Table Cook Pharmica Parenteral Drugs Product Introduction, Application and Specification
Table Cook Pharmica Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cook Pharmica Parenteral Drugs Production Growth Rate (2014-2019)
Table Cook Pharmica Parenteral Drugs Production Market Share (2014-2019)
Figure Cook Pharmica Parenteral Drugs Revenue Market Share (2014-2019)
Table Cook Pharmica Parenteral Drugs Main Business and Markets Served
Table Patheon Parenteral Drugs Production Sites and Area Served
Table Patheon Parenteral Drugs Product Introduction, Application and Specification
Table Patheon Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Patheon Parenteral Drugs Production Growth Rate (2014-2019)
Table Patheon Parenteral Drugs Production Market Share (2014-2019)
Figure Patheon Parenteral Drugs Revenue Market Share (2014-2019)
Table Patheon Parenteral Drugs Main Business and Markets Served
Table BAG Healthcare Parenteral Drugs Production Sites and Area Served
Table BAG Healthcare Parenteral Drugs Product Introduction, Application and Specification
Table BAG Healthcare Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BAG Healthcare Parenteral Drugs Production Growth Rate (2014-2019)
Table BAG Healthcare Parenteral Drugs Production Market Share (2014-2019)
Figure BAG Healthcare Parenteral Drugs Revenue Market Share (2014-2019)
Table BAG Healthcare Parenteral Drugs Main Business and Markets Served
Table Beximco Pharma Parenteral Drugs Production Sites and Area Served
Table Beximco Pharma Parenteral Drugs Product Introduction, Application and Specification
Table Beximco Pharma Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Beximco Pharma Parenteral Drugs Production Growth Rate (2014-2019)
Table Beximco Pharma Parenteral Drugs Production Market Share (2014-2019)
Figure Beximco Pharma Parenteral Drugs Revenue Market Share (2014-2019)
Table Beximco Pharma Parenteral Drugs Main Business and Markets Served
Table Baxter Healthcare Corporation Parenteral Drugs Production Sites and Area Served
Table Baxter Healthcare Corporation Parenteral Drugs Product Introduction, Application and Specification
Table Baxter Healthcare Corporation Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter Healthcare Corporation Parenteral Drugs Production Growth Rate (2014-2019)
Table Baxter Healthcare Corporation Parenteral Drugs Production Market Share (2014-2019)
Figure Baxter Healthcare Corporation Parenteral Drugs Revenue Market Share (2014-2019)
Table Baxter Healthcare Corporation Parenteral Drugs Main Business and Markets Served
Table B. Braun Parenteral Drugs Production Sites and Area Served
Table B. Braun Parenteral Drugs Product Introduction, Application and Specification
Table B. Braun Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table B. Braun Parenteral Drugs Production Growth Rate (2014-2019)
Table B. Braun Parenteral Drugs Production Market Share (2014-2019)
Figure B. Braun Parenteral Drugs Revenue Market Share (2014-2019)
Table B. Braun Parenteral Drugs Main Business and Markets Served
Table Fresenius Parenteral Drugs Production Sites and Area Served
Table Fresenius Parenteral Drugs Product Introduction, Application and Specification
Table Fresenius Parenteral Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Fresenius Parenteral Drugs Production Growth Rate (2014-2019)
Table Fresenius Parenteral Drugs Production Market Share (2014-2019)
Figure Fresenius Parenteral Drugs Revenue Market Share (2014-2019)
Table Fresenius Parenteral Drugs Main Business and Markets Served
Table Albert David Parenteral Drugs Production Sites and Area Served
Table BML Parenteral Drugs Parenteral Drugs Production Sites and Area Served
Table Pfizer (Hospira) Parenteral Drugs Production Sites and Area Served
Table Pisa Parenteral Drugs Production Sites and Area Served
Table Ozon Pharmaceuticals Ltd Parenteral Drugs Production Sites and Area Served
Table Aspen Holdings Parenteral Drugs Production Sites and Area Served
Table PSI Ltd Parenteral Drugs Production Sites and Area Served
Table Wintac Limited Parenteral Drugs Production Sites and Area Served
Table AXA Parenterals Ltd Parenteral Drugs Production Sites and Area Served
Table Acebright Parenteral Drugs Production Sites and Area Served
Table Southwest Pharmaceutical Parenteral Drugs Production Sites and Area Served
Table Abbott Parenteral Drugs Production Sites and Area Served
Figure Global Parenteral Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Parenteral Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Parenteral Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Parenteral Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Parenteral Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Parenteral Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Parenteral Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Parenteral Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Parenteral Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Parenteral Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Parenteral Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Parenteral Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Parenteral Drugs by Application (2019-2025)
Table Parenteral Drugs Distributors List
Table Parenteral Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の大容量非経口（LVP）市場：動向・競争分析 Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral pre…- 非経口包装の世界市場：インサイト・予測 Packaging in parenteral is a process that allows the drug or other fluid to keep its potency and therapeutic effectiveness intact throughout the shelf life or till the time the drug is administered. Effective packaging in parenteral is required to protect drugs from contamination and aseptic adminis…
- 多発性硬化症薬の世界市場：市場規模・現状・予測 Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the s…
- タイサブリ薬の世界市場：インサイト・予測 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…
- メチシリン耐性黄色ブドウ球菌 (MRSA)薬の世界市場：インサイト・予測 Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. …